Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7008 matches for

A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.

© Image credit: Gates Archive/Samantha Reinders
Rinn Song

Rinn Song

Rinn Song - Clinical Scientist

Emma Francis

Emma Francis

Emma Francis - Research Practitioner

Amber Thompson

Amber Thompson

Amber Thompson - Senior QA and Sample Compliance Manager

Roshni Mansfield

Roshni Mansfield

Yama G.Farooq

Yama G.Farooq

BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director

Rebecca Beckley

Rebecca Beckley

Rebecca Beckley - Project Manager

James Gilchrist

James Gilchrist

MBioch, MBBS, MRCPCH, DPhil, PGDip Paediatric Infectious Diseases James Gilchrist - Wellcome Career Development Fellow

Mercy Macharia

Mercy Macharia

Rachel Anslow

Rachel Anslow

Rachel Anslow - Senior Research Assistant

Kai Gao

Kai Gao

Seung Joon Kim

Seung Joon Kim

Pip Crowley

Pip Crowley

Philip Taylor

Philip Taylor

Manon Chatain

Manon Chatain

Manon Chatain - Clinical Research Practitioner

Jo Ning

Jo Ning - Research Assistant

Jesus Caro

Jesus Caro

Jack Howes

Jack Howes

Anna Kelly

Anna Kelly

Hannah Hart

Hannah Hart

Abi Preston-Rees

Abi Preston-Rees

Load More

Similar stories

New MenB Vaccine Shows Promise in Early-Stage Trial Results

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group B meningococcus (MenB), a significant cause of meningococcal disease worldwide, and establishes proof-of-concept in humans that a gene-based vaccine platform can induce protective antibody responses against bacteria.

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Spotlight on Magdalen College Chapel for Rare Disease Day

New partnership to advance public health and life science research collaboration in West Africa

New study shows that early support for children living in marginalised communities can improve their developmental outcomes

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies